Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
about
Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococciNosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit.Interactions between glycopeptides and beta-lactams against isogenic pairs of teicoplanin-susceptible and -resistant strains of Staphylococcus haemolyticusReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsThe Three Bacterial Lines of Defense against Antimicrobial AgentsCellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteriaEmergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli.Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection modelCharacterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptidesStaphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytesReduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) functionVancomycin resistance in staphylococci.Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapyInteractions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.Molecular detection of antimicrobial resistanceIn vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action.Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus.Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactamReversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolatesCharacterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection modelStructural and topological differences between a glycopeptide-intermediate clinical strain and glycopeptide-susceptible strains of Staphylococcus aureus revealed by atomic force microscopyA spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolatesBactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in viDaptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases.An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus.Effect of low temperature on growth and ultra-structure of Staphylococcus sppProduction of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibilityMechanisms of antibiotic resistance in Staphylococcus aureus.Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
P2860
Q24519004-809C4DF0-0761-4AAC-8305-7F081B2D078DQ24532922-210AF4A4-E021-419D-8C8A-65006AD25855Q24549505-A5038BA0-3856-4C2C-BB5C-30C6DB0B8713Q24646677-EA6EEA77-CB08-47B3-BA8A-7EDDF32F9C10Q26786956-CE037B59-E192-4030-A850-3E9C6A875CAEQ28217016-18F7D4DF-D4D4-48FC-9A70-D5A4F8A75E1AQ31131146-8A096D7A-D2CF-4519-8EB6-36501B590F27Q33264418-231A8556-37F3-4D48-8933-0684B97B9878Q33301093-A20E8422-326D-4CAD-8900-D9631711C11DQ33593883-7EAD77BA-3346-4D62-BB44-8413FB322BCDQ33661713-AA3AC316-C70C-488D-B29F-DE010C39DB95Q33719311-26B8E3B4-C5DA-45B9-8126-8C33194FA1D2Q33883752-547D1AFA-E823-44CC-B0C3-E17F32363AB4Q33906522-1AF344D5-2C7D-4137-9B55-EC95B0F80547Q33939095-6FFCAD27-6F66-42D2-AB53-DC03E58BBBDEQ33958003-B3F1A286-4A69-4F7E-92A6-5D10F20F3BFCQ33962676-D1C92EF5-6CFA-4F05-8242-A6C19947FEE1Q33965630-E57C9F2B-1CB2-4DD7-B68C-FC5FD3B1E597Q33966785-A9E5FBDE-BEE3-43AE-A8C8-18F1C26DED05Q33974326-F2F2418C-15AE-4B4C-BA23-E895AB9729F1Q33975793-780C8442-2BDA-41D8-9256-F93D4FB1AE38Q33976229-918A7559-2EB6-453E-9A5E-C681216BC766Q33977223-1881E620-98C4-4EB3-B128-22D6DF7E241FQ33977356-28B8FBEA-BE14-466F-8806-2071F7CA7120Q33977947-BE55B430-9C43-48CC-8464-0F5F481FAB05Q33978642-2D80B1FF-73AB-44D4-87A5-3741BF225BE5Q33978671-FFD26066-DFEC-4CD1-A02E-7AA652A7E16EQ33979347-3482D733-C67F-4A1C-A2D4-536FBA2EFE09Q33979572-44EAC8D0-D8F2-4B10-BA8A-0682FC02166EQ33980074-D3064774-A0F1-4F4C-9E4B-48DAD6AC8941Q33981064-94077B8D-60C6-480B-BA13-778F0FA01351Q33981239-618898A1-9C61-4C7B-8C40-142D72C72F06Q33981366-86BA40F2-4139-408E-85CF-2D7201C976B2Q34045273-2FC8F031-F8A2-42CE-BE5D-00E7D70790C6Q34092336-84918D18-5297-4BA0-9364-1DC6686D1DDEQ34142416-24426F21-1D73-46AD-BE83-7B4881050D5FQ34145802-8EAE2721-A745-445D-AEE8-D2B7F1F5B4F3Q34632683-D3019A5C-0543-4209-94CE-12AD3E9D3A62Q34657311-D4ABC986-835C-48E7-B812-405529743C66Q34823746-268BC7EF-988F-4473-BF16-F88C43FCDB9B
P2860
Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@ast
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@en
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@nl
type
label
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@ast
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@en
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@nl
prefLabel
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@ast
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@en
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@nl
P2860
P1476
Inhibition of cell wall turnov ...... utant of Staphylococcus aureus
@en
P2093
K Sieradzki
P2860
P304
P356
10.1128/JB.179.8.2557-2566.1997
P407
P577
1997-04-01T00:00:00Z